Search research articles
Contact Us
Filters
Showing results (451-460 of 468) with videos related to
Page
of 47
Sort By:
Neuro-Oncology Advances
|
May 19, 2021
The state of neuro-oncology during the COVID-19 pandemic: a worldwide assessment
Maciej M Mrugala, Quinn T Ostrom, Shelley M Pressley, et al.
Immunity
|
August 7, 2024
The cytokine Meteorin-like inhibits anti-tumor CD8<sup>+</sup> T cell responses by disrupting mitochondrial function
Christopher M Jackson, Ayush Pant, Wikum Dinalankara, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 14, 2026
Evaluation of Regorafenib in Newly Diagnosed and Recurrent Glioblastoma: GBM AGILE Phase II/III Bayesian Randomized Platform Trial
Patrick Y Wen, Donald A Berry, Meredith B Buxton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 7, 2026
Erratum: Evaluation of Regorafenib in Newly Diagnosed and Recurrent Glioblastoma: GBM AGILE Phase II/III Bayesian Randomized Platform Trial
Patrick Y Wen, Donald A Berry, Meredith B Buxton, et al.
Journal for Immunotherapy of Cancer
|
November 17, 2020
Defining best practices for tissue procurement in immuno-oncology clinical trials: consensus statement from the Society for Immunotherapy of Cancer Surgery Committee
Brian Gastman, Piyush K Agarwal, Adam Berger, et al.
Nature Medicine
|
July 24, 2023
Correcting the drug development paradigm for glioblastoma requires serial tissue sampling
Kirit Singh, Kelly M Hotchkiss, Ian F Parney, et al.
Medrxiv : the Preprint Server for Health Sciences
|
December 16, 2024
Detection of human brain cancers using genomic and immune cell characterization of cerebrospinal fluid through CSF-BAM
Alexander H Pearlman, Yuxuan Wang, Anita Kalluri, et al.
Genome Biology
|
August 28, 2020
Transcriptional regulatory networks of tumor-associated macrophages that drive malignancy in mesenchymal glioblastoma
Jason K Sa, Nakho Chang, Hye Won Lee, et al.
Neuro-Oncology
|
December 28, 2020
Unique challenges for glioblastoma immunotherapy-discussions across neuro-oncology and non-neuro-oncology experts in cancer immunology. Meeting Report from the 2019 SNO Immuno-Oncology Think Tank
Pavlina Chuntova, Frances Chow, Payal B Watchmaker, et al.
Cell Reports. Medicine
|
August 8, 2023
Seq-ing the SINEs of central nervous system tumors in cerebrospinal fluid
Christopher Douville, Samuel Curtis, Mahmoud Summers, et al.
Page
of 47
Search research articles
Search
Showing results (451-460 of 468) with videos related to
Sort By:
Page
of 47
Neuro-Oncology Advances
|
May 19, 2021
The state of neuro-oncology during the COVID-19 pandemic: a worldwide assessment
Maciej M Mrugala, Quinn T Ostrom, Shelley M Pressley, et al.
Immunity
|
August 7, 2024
The cytokine Meteorin-like inhibits anti-tumor CD8<sup>+</sup> T cell responses by disrupting mitochondrial function
Christopher M Jackson, Ayush Pant, Wikum Dinalankara, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 14, 2026
Evaluation of Regorafenib in Newly Diagnosed and Recurrent Glioblastoma: GBM AGILE Phase II/III Bayesian Randomized Platform Trial
Patrick Y Wen, Donald A Berry, Meredith B Buxton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 7, 2026
Erratum: Evaluation of Regorafenib in Newly Diagnosed and Recurrent Glioblastoma: GBM AGILE Phase II/III Bayesian Randomized Platform Trial
Patrick Y Wen, Donald A Berry, Meredith B Buxton, et al.
Journal for Immunotherapy of Cancer
|
November 17, 2020
Defining best practices for tissue procurement in immuno-oncology clinical trials: consensus statement from the Society for Immunotherapy of Cancer Surgery Committee
Brian Gastman, Piyush K Agarwal, Adam Berger, et al.
Nature Medicine
|
July 24, 2023
Correcting the drug development paradigm for glioblastoma requires serial tissue sampling
Kirit Singh, Kelly M Hotchkiss, Ian F Parney, et al.
Medrxiv : the Preprint Server for Health Sciences
|
December 16, 2024
Detection of human brain cancers using genomic and immune cell characterization of cerebrospinal fluid through CSF-BAM
Alexander H Pearlman, Yuxuan Wang, Anita Kalluri, et al.
Genome Biology
|
August 28, 2020
Transcriptional regulatory networks of tumor-associated macrophages that drive malignancy in mesenchymal glioblastoma
Jason K Sa, Nakho Chang, Hye Won Lee, et al.
Neuro-Oncology
|
December 28, 2020
Unique challenges for glioblastoma immunotherapy-discussions across neuro-oncology and non-neuro-oncology experts in cancer immunology. Meeting Report from the 2019 SNO Immuno-Oncology Think Tank
Pavlina Chuntova, Frances Chow, Payal B Watchmaker, et al.
Cell Reports. Medicine
|
August 8, 2023
Seq-ing the SINEs of central nervous system tumors in cerebrospinal fluid
Christopher Douville, Samuel Curtis, Mahmoud Summers, et al.
Page
of 47